74 studies found for:    "Sclerosis" AND (woman OR women OR female)
Show Display Options
Rank Status Study
21 Completed The Effect of Sildenafil Citrate (Viagra® (Registered Trademark)) on Brain Blood Flow in Multiple Sclerosis Patients
Condition: Multiple Sclerosis
Intervention:
22 Completed Phase 3 Study of Dexpramipexole in ALS
Condition: Amyotrophic Lateral Sclerosis
Interventions: Drug: Dexpramipexole;   Drug: Placebo
23 Terminated Phase 3 Extension Study of Dexpramipexole in ALS
Condition: Amyotrophic Lateral Sclerosis
Intervention: Drug: Dexpramipexole
24 Recruiting An Efficacy and Safety Study of BG00012 (Dimethyl Fumarate) in Asian Subjects With Relapsing Remitting Multiple Sclerosis (RRMS)
Conditions: Relapsing-Remitting Multiple Sclerosis;   Multiple Sclerosis
Interventions: Drug: Placebo;   Drug: BG00012 (dimethyl fumarate)
25 Recruiting Action of Baclofen Capsules in Spasticity Due to Multiple Sclerosis
Condition: Spasticity
Interventions: Drug: Baclofen dose 1;   Drug: Baclofen dose 2;   Drug: Placebo
26 Recruiting Trial of RAD001 and Neurocognition in Tuberous Sclerosis Complex (TSC)
Condition: Tuberous Sclerosis Complex
Intervention: Drug: RAD001
27 Completed Evaluation of an Altered Peptide Ligand (NBI-5788) in Patients With Relapsing Multiple Sclerosis (MS)
Condition: Multiple Sclerosis
Intervention: Drug: NBI-5788
28 Completed Safety and Efficacy of Natalizumab in Combination With Avonex in the Treatment of Multiple Sclerosis
Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Drug: Natalizumab;   Drug: Placebo
29 Completed Treatment of Multiple Sclerosis With Copaxone and Albuterol
Conditions: Autoimmune Diseases;   Multiple Sclerosis
Interventions: Drug: Glatiramer acetate;   Drug: Albuterol;   Drug: Albuterol placebo
30 Completed A Serologic Study to Correlate Beta-IFN NAb Titers to Beta-IFN Induced Biomarker Response in Patients With Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention:
31 Completed Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two
Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Biological: alemtuzumab;   Biological: interferon beta-1a (Rebif®)
32 Completed Safety and Efficacy of Natalizumab in the Treatment of Multiple Sclerosis
Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Drug: Natalizumab;   Drug: Placebo
33 Recruiting Pregnancy Registry Trial
Condition: Multiple Sclerosis
Intervention: Drug: Fingolimod
34 Recruiting Observational Study for Assessment of the Effect of Fampyra on the Manual Function of Persons With Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention:
35 Completed Betaseron Pregnancy Registry
Conditions: Birth Defects;   Pregnancy Complications;   Multiple Sclerosis
Intervention:
36 Completed Assessment of Repeat Ascending Doses of GSK2018682 in Healthy Volunteers
Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Drug: GSK2018682;   Drug: Placebo
37 Unknown  Doxycycline In Lymphangioleiomyomatosis (LAM)
Conditions: Lymphangioleiomyomatosis;   Tuberous Sclerosis
Interventions: Drug: Doxycycline;   Drug: Placebo
38 Unknown  Cistanche Total Glycosides for Amyotrophic Lateral Sclerosis: A Randomized Control Trial (RCT) Study Assessing Clinical Response
Condition: Amyotrophic Lateral Sclerosis
Intervention: Drug: Cistanche Total Glycosides
39 Completed G-CSF Treatment for Amyotrophic Lateral Sclerosis: A RCT Study Assessing Clinical Response
Condition: Amyotrophic Lateral Sclerosis
Interventions: Drug: Granulocyte Colony Stimulating Factor;   Drug: NS
40 Recruiting Cervical Spinal Cord Metabolism and Microstructure in Amyotrophic Lateral Sclerosis(ALS)
Condition: Amyotrophic Lateral Sclerosis
Intervention: Procedure: Amyotrophic Lateral Sclerosis

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years